Mandate

Fabege acquires Tornet property

July 20, 2006

Fabege AB has signed an agreement to acquire the remaining shares in the Fastighets AB Tornet. Fabege has owned 82.4% of the shares in Tornet for a while and this sale concerns the remaining 16.7 percent. The cash option of 146 Swedish Kronor per share involves an offer valued at approximately SEK 665 million.

Vinge acted as advisor to Fabege AB in the acquisition. Representatives from Vinge included Jan Lomback, Patrick Forslund and Mattias Friberg.

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026